New Frontiers in Asymmetric Catalysis

┬╖
┬╖ John Wiley & Sons
рдИ-рдкреБрд╕реНрддрдХ
448
рдкреЗрдЬ
рд░реЗрдЯрд┐рдВрдЧ рдЖрдгрд┐ рдкрд░реАрдХреНрд╖рдгреЗ рдпрд╛рдВрдЪреА рдкрдбрддрд╛рд│рдгреА рдХреЗрд▓реЗрд▓реА рдирд╛рд╣реА ┬ардЕрдзрд┐рдХ рдЬрд╛рдгреВрди рдШреНрдпрд╛

рдпрд╛ рдИ-рдкреБрд╕реНрддрдХрд╛рд╡рд┐рд╖рдпреА

A compilation of recent advances and applications in asymmetric catalysis

The field of asymmetric catalysis has grown rapidly and plays a key role in drug discovery and pharmaceuticals. New Frontiers in Asymmetric Catalysis gives readers a fundamental understanding of the concepts and applications of asymmetric catalysis reactions and discusses the latest developments and findings. With contributions from preeminent scientists in their respective fields, it covers:

* "Rational" ligand design, which is critically dependent on the reaction type (reduction, oxidation, and C-C bond formation)
* Recent findings on activation of C-H bonds, C-C bonds, and small molecules (C=O, HCN, RN=C, and CO2) and the latest developments on C-C bond reorganization, such as metathesis
* Advances in "chirally economical" non-linear phenomena, racemic catalysis, and autocatalysis
* Some of the recent discoveries that have led to a renaissance in the field of organocatalysis, including the development of chiral Br├╢nstead acids and Lewis acidic metals bearing the conjugate base of the Br├╢nstead acids as the ligands and the chiral bi-functional acid/base catalysts

The book ends with a thought-provoking perspective on the future of asymmetric catalysis that addresses both the challenges and the unlimited potential in this burgeoning field. This is an authoritative, up-to-date reference for organic chemists in academia, government, and industries, including pharmaceuticals, biotech, fine chemicals, polymers, and agriculture. It is also an excellent textbook for graduate students studying advanced organic chemistry or chemical synthesis.

рд▓реЗрдЦрдХрд╛рд╡рд┐рд╖рдпреА

Koichi Mikami is Professor in the Department of Applied Chemistry at the Tokyo Institute of Technology.

Mark Lautens is AstraZeneca Professor of Organic Synthesis and Merck Frosst/NSERC Industrial Research Chair in the Davenport Laboratories at the University of Toronto.

рдпрд╛ рдИ-рдкреБрд╕реНрддрдХрд▓рд╛ рд░реЗрдЯрд┐рдВрдЧ рджреНрдпрд╛

рддреБрдореНрд╣рд╛рд▓рд╛ рдХрд╛рдп рд╡рд╛рдЯрддреЗ рддреЗ рдЖрдореНрд╣рд╛рд▓рд╛ рд╕рд╛рдВрдЧрд╛.

рд╡рд╛рдЪрди рдорд╛рд╣рд┐рддреА

рд╕реНрдорд╛рд░реНрдЯрдлреЛрди рдЖрдгрд┐ рдЯреЕрдмрд▓реЗрдЯ
Android рдЖрдгрд┐ iPad/iPhone рд╕рд╛рдареА Google Play рдмреБрдХ рдЕтАНреЕрдк рдЗрдВрд╕реНтАНрдЯреЙрд▓ рдХрд░рд╛. рд╣реЗ рддреБрдордЪреНтАНрдпрд╛ рдЦрд╛рддреНтАНрдпрд╛рдиреЗ рдЖрдкреЛрдЖрдк рд╕рд┐рдВрдХ рд╣реЛрддреЗ рдЖрдгрд┐ рддреБрдореНтАНрд╣реА рдЬреЗрдереЗ рдХреБрдареЗ рдЕрд╕рд╛рд▓ рддреЗрдереВрди рддреБрдореНтАНрд╣рд╛рд▓рд╛ рдСрдирд▓рд╛рдЗрди рдХрд┐рдВрд╡рд╛ рдСрдлрд▓рд╛рдЗрди рд╡рд╛рдЪрдгреНтАНрдпрд╛рдЪреА рдЕрдиреБрдорддреА рджреЗрддреЗ.
рд▓реЕрдкрдЯреЙрдк рдЖрдгрд┐ рдХреЙрдВрдкреНрдпреБрдЯрд░
рддреБрдореНрд╣реА рддреБрдордЪреНрдпрд╛ рдХрд╛рдБрдкреНрдпреБрдЯрд░рдЪрд╛ рд╡реЗрдм рдмреНрд░рд╛рдЙрдЭрд░ рд╡рд╛рдкрд░реВрди Google Play рд╡рд░ рдЦрд░реЗрджреА рдХреЗрд▓реЗрд▓реА рдСрдбрд┐рдУрдмреБрдХ рдРрдХреВ рд╢рдХрддрд╛.
рдИрд╡рд╛рдЪрдХ рдЖрдгрд┐ рдЗрддрд░ рдбрд┐рд╡реНрд╣рд╛рдЗрд╕реЗрд╕
Kobo eReaders рд╕рд╛рд░рдЦреНрдпрд╛ рдИ-рдЗрдВрдХ рдбрд┐рд╡реНтАНрд╣рд╛рдЗрд╕рд╡рд░ рд╡рд╛рдЪрдгреНтАНрдпрд╛рд╕рд╛рдареА, рддреБрдореНрд╣реА рдПрдЦрд╛рджреА рдлрд╛рдЗрд▓ рдбрд╛рдЙрдирд▓реЛрдб рдХрд░реВрди рддреА рддреБрдордЪреНтАНрдпрд╛ рдбрд┐рд╡реНтАНрд╣рд╛рдЗрд╕рд╡рд░ рдЯреНрд░рд╛рдиреНрд╕рдлрд░ рдХрд░рдгреЗ рдЖрд╡рд╢реНрдпрдХ рдЖрд╣реЗ. рд╕рдкреЛрд░реНрдЯ рдЕрд╕рд▓реЗрд▓реНрдпрд╛ eReaders рд╡рд░ рдлрд╛рдЗрд▓ рдЯреНрд░рд╛рдиреНрд╕рдлрд░ рдХрд░рдгреНрдпрд╛рд╕рд╛рдареА, рдорджрдд рдХреЗрдВрджреНрд░ рдордзреАрд▓ рддрдкрд╢реАрд▓рд╡рд╛рд░ рд╕реВрдЪрдирд╛ рдлреЙрд▓реЛ рдХрд░рд╛.